TIGIT is mainly expressed on the surface of activated T cells and NK cells, and its receptors are primarily poliovirus receptors (PVR, CD155) and VR-like protein 2 (PVRL2, CD122), which are highly expressed in tumor cells and APCs, and are newly discovered immune checkpoint ligands. This evidence concerns the gene PVR and neoplasm.